GGrantIndex
← Leaderboards

Margaret A Shipp

Dana-Farber Cancer Institute

Google Scholar ↗PubMed ↗ORCID ↗
$7,796,368
Attributed
$7,796,368
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $4.8M · FY2005–20
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$40,736,479 · 9

By mechanism

P01$35,248,423 · 5
R01$4,735,203 · 2
P30$752,853 · 2

Top collaborators

No co-investigators on record.

Most similar at Dana-Farber Cancer Institute

Same institution · by research overlap

Others in their field

Top investigators on “Base”

Research focus

BaseMalignant Lymphoid NeoplasmMolecularClinical TrialsHodgkin DiseaseInsightImmune ResponseMolecular ProfilingB-Cell LymphomasResearch PersonnelTranslatingRecurrenceInterestMalignant NeoplasmsLymphoid NeoplasmInhibitor/AntagonistMutationFundingParticipantPredisposing FactorLymphomaProgramsGuidelinesDana-Farber Cancer Institute

Grant awards (55)

Targetable Immune Evasion Pathways in Hodgkin Lymphoma$373,399
R01 · FY2020 · CA · contact PI
Program 6: Lymphoma and Myeloma$73,623
P30 · FY2020 · CA · contact PI
Program 6: Lymphoma and Myeloma$2,948
P30 · FY2020 · CA · contact PI
Targetable Immune Evasion Pathways in Hodgkin Lymphoma$362,197
R01 · FY2019 · CA · contact PI
Program 6: Lymphoma and Myeloma$71,991
P30 · FY2019 · CA · contact PI
Program 6: Lymphoma and Myeloma$6,168
P30 · FY2019 · CA · contact PI
Targetable Immune Evasion Pathways in Hodgkin Lymphoma$373,399
R01 · FY2018 · CA · contact PI
Program 6: Lymphoma and Myeloma$73,653
P30 · FY2018 · CA · contact PI
Program 6: Lymphoma and Myeloma$11,431
P30 · FY2018 · CA · contact PI
Program 6: Lymphoma and Myeloma$5,849
P30 · FY2018 · CA · contact PI
Program 6: Lymphoma and Myeloma$5,123
P30 · FY2018 · CA · contact PI
Program 6: Lymphoma and Myeloma$3,833
P30 · FY2018 · CA · contact PI
Program 6: Lymphoma and Myeloma$1,602
P30 · FY2018 · CA · contact PI
Targetable Immune Evasion Pathways in Hodgkin Lymphoma$373,399
R01 · FY2017 · CA · contact PI
Program 6: Lymphoma and Myeloma$43,077
P30 · FY2017 · CA · contact PI
Targetable Immune Evasion Pathways in Hodgkin Lymphoma$410,899
R01 · FY2016 · CA · contact PI
Lymphoma and Myeloma$93,216
P30 · FY2016 · CA · contact PI
Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies$425,165
R01 · FY2015 · CA · contact PI
Lymphoma and Myeloma$93,249
P30 · FY2015 · CA · contact PI
Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies$413,783
R01 · FY2014 · CA · contact PI
Lymphoma and Myeloma$88,354
P30 · FY2014 · CA · contact PI
Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies$402,341
R01 · FY2013 · CA · contact PI
Lymphoma and Myeloma$85,505
P30 · FY2013 · CA · contact PI
Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies$410,749
R01 · FY2012 · CA · contact PI
Lymphoma and Myeloma$93,231
P30 · FY2012 · CA · contact PI
Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies$449,734
R01 · FY2011 · CA · contact PI
PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas$75,000
P01 · FY2011 · CA · contact PI
PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas$3,344,713
P01 · FY2010 · CA · contact PI
Molecular Heterogeneity and Rational Thereapeutic Targets in Large B-Cell Lymphom$351,131
P01 · FY2010 · CA · contact PI
Administrative$114,111
P01 · FY2010 · CA · contact PI
PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas$3,316,818
P01 · FY2009 · CA · contact PI
PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas$1,061,795
P01 · FY2009 · CA · contact PI
Molecular Heterogeneity and Rational Thereapeutic Targets in Large B-Cell Lymphom$349,556
P01 · FY2009 · CA · contact PI
Administrative$114,354
P01 · FY2009 · CA · contact PI
PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas$3,233,354
P01 · FY2008 · CA · contact PI
Molecular Heterogeneity and Rational Thereapeutic Targets in Large B-Cell Lymphom$295,236
P01 · FY2008 · CA · contact PI
Administrative$97,230
P01 · FY2008 · CA · contact PI
PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas$3,214,174
P01 · FY2007 · CA · contact PI
Molecular Heterogeneity and Rational Thereapeutic Targets in Large B-Cell Lymphom$288,580
P01 · FY2007 · CA · contact PI
Administrative$95,684
P01 · FY2007 · CA · contact PI
PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas$3,219,425
P01 · FY2006 · CA · contact PI
Molecular Heterogeneity and Rational Thereapeutic Targets in Large B-Cell Lymphom$282,115
P01 · FY2006 · CA · contact PI
Administrative$94,181
P01 · FY2006 · CA · contact PI
Molecular Targets of Germinal Center B Cell Lymphomas$3,285,136
P01 · FY2005 · CA
Molecular Targets of Germinal Center B Cell Lymphomas$3,197,290
P01 · FY2004 · CA
Molecular Targets of Germinal Center B Cell Lymphomas$3,109,897
P01 · FY2003 · CA
Molecular Targets of Germinal Center B Cell Lymphomas$2,976,629
P01 · FY2002 · CA
STROMELYSIN 3 AND THE TUMOR MICROENVIRONMENT$252,387
R01 · FY2002 · CA
SIGNATURES OF OUTCOME IN GERMINAL CENTER B CELL LYMPHOMA$0
P01 · FY2002 · CA
Molecular Targets of Germinal Center B Cell Lymphomas$2,905,880
P01 · FY2001 · CA
STROMELYSIN 3 AND THE TUMOR MICROENVIRONMENT$246,645
R01 · FY2001 · CA
SIGNATURES OF OUTCOME IN GERMINAL CENTER B CELL LYMPHOMA$0
P01 · FY2001 · CA
BIOLOGICAL HETEROGENEITY OF AGGRESSIVE NONHODGKINS LYMPHOMA$0
P01 · FY2001 · CA
STROMELYSIN 3 AND THE TUMOR MICROENVIRONMENT$241,106
R01 · FY2000 · CA
BIOLOGICAL HETEROGENEITY OF AGGRESSIVE NONHODGKINS LYMPHOMA$226,134
P01 · FY2000 · CA